Home - Products - Others - Other Targets - Isorhamnetin-3-O-neohespeidoside

Isorhamnetin-3-O-neohespeidoside

CAS No. 55033-90-4

Isorhamnetin-3-O-neohespeidoside( —— )

Catalog No. M14990 CAS No. 55033-90-4

Isorhamnetin-3-O-neohespeidoside is a flavonol glycoside extract used as an anti-oxidant.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 137 In Stock
25MG 245 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Isorhamnetin-3-O-neohespeidoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Isorhamnetin-3-O-neohespeidoside is a flavonol glycoside extract used as an anti-oxidant.
  • Description
    Isorhamnetin-3-O-neohespeidoside is a flavonol glycoside extract used as an anti-oxidant.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    55033-90-4
  • Formula Weight
    624.54
  • Molecular Formula
    C28H32O16
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Pyridine, Methanol, Ethanol
  • SMILES
    C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)OC)CO)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li CY,et al. Measurement of hydroxysafflor yellow A in human urine by liquid chromatography-tandem mass spectrometry.J Chromatogr B Analyt Technol Biomed Life Sci.
molnova catalog
related products
  • Hydroxy Dimetridazol...

    Hydroxy Dimetridazole is a hydroxy metabolite of Dimetridazole which combats protozoan infections.

  • AC-264613

    AC-264613 is an agonist of the GPCR protease-activated receptor 2 (PAR2).

  • AU-15330

    AU-15330 is a proteolytic targeting chimera (PROTAC) that simultaneously targets SMARCA4, SMARCA2, and PBRM1 for degradation and exhibits cytotoxicity in H3.3K27M cells but not in H3 wild-type cells.